Amphastar Pharmaceuticals Inc (AMPH)
44.54
+0.45
(+1.02%)
USD |
NASDAQ |
Nov 21, 16:00
44.54
0.00 (0.00%)
After-Hours: 20:00
Amphastar Pharmaceuticals Price: 44.54 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 43.71 | 44.54 | 43.09 | 44.09 | 607032.0 |
| Nov 19, 2024 | 43.80 | 44.26 | 43.21 | 43.62 | 432586.0 |
| Nov 18, 2024 | 44.39 | 44.86 | 44.00 | 44.16 | 343046.0 |
| Nov 15, 2024 | 45.07 | 45.39 | 43.88 | 44.61 | 408672.0 |
| Nov 14, 2024 | 45.48 | 45.90 | 44.71 | 45.06 | 359021.0 |
| Nov 13, 2024 | 47.51 | 47.99 | 45.38 | 45.48 | 421188.0 |
| Nov 12, 2024 | 48.38 | 49.12 | 47.48 | 47.71 | 364171.0 |
| Nov 11, 2024 | 48.52 | 49.16 | 47.37 | 48.57 | 382477.0 |
| Nov 08, 2024 | 46.18 | 49.52 | 46.03 | 48.31 | 626887.0 |
| Nov 07, 2024 | 47.94 | 49.45 | 46.03 | 46.09 | 1.367M |
| Nov 06, 2024 | 52.05 | 53.96 | 52.05 | 53.40 | 611837.0 |
| Nov 05, 2024 | 50.59 | 51.72 | 50.33 | 51.56 | 199229.0 |
| Nov 04, 2024 | 50.72 | 51.53 | 50.26 | 50.59 | 376573.0 |
| Nov 01, 2024 | 50.75 | 51.22 | 50.25 | 50.73 | 181298.0 |
| Oct 31, 2024 | 50.39 | 51.35 | 50.04 | 50.53 | 266346.0 |
| Oct 30, 2024 | 50.42 | 51.57 | 50.42 | 50.78 | 289255.0 |
| Oct 29, 2024 | 51.29 | 51.36 | 50.55 | 51.15 | 180767.0 |
| Oct 28, 2024 | 50.57 | 51.84 | 50.53 | 51.41 | 338028.0 |
| Oct 25, 2024 | 50.00 | 50.55 | 49.80 | 50.29 | 179571.0 |
| Oct 24, 2024 | 49.68 | 51.36 | 49.38 | 49.63 | 465917.0 |
| Oct 23, 2024 | 50.40 | 50.63 | 49.47 | 49.83 | 314643.0 |
| Oct 22, 2024 | 50.59 | 51.02 | 50.20 | 50.38 | 188623.0 |
| Oct 21, 2024 | 50.83 | 51.42 | 50.08 | 50.82 | 208996.0 |
| Oct 18, 2024 | 49.87 | 51.44 | 49.83 | 50.84 | 245274.0 |
| Oct 17, 2024 | 51.27 | 51.35 | 49.48 | 49.71 | 272772.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
12.66
Minimum
Mar 20 2020
65.00
Maximum
Aug 08 2023
31.77
Average
28.86
Median
Price Benchmarks
| Eli Lilly and Co | 749.91 |
| BridgeBio Pharma Inc | 23.26 |
| NovaBay Pharmaceuticals Inc | 0.718 |
| Palatin Technologies Inc | 0.91 |
| iBio Inc | 2.45 |
Price Related Metrics
| PE Ratio | 14.85 |
| PS Ratio | 3.231 |
| PEG Ratio | 0.8638 |
| Price to Book Value | 2.943 |
| Price to Free Cash Flow | 13.74 |
| Earnings Yield | 6.74% |
| Market Cap | 2.142B |
| PEGY Ratio | 0.8638 |
| Operating PE Ratio | 10.91 |
| Normalized PE Ratio | 14.85 |